Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

ARFORMOTEROL TARTRATE

ARFORMOTEROL TARTRATE

Standard Dose
EQ 0.015MG BASE/2ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ARFORMOTEROL TARTRATE is listed in Drugs@FDA under application 218555 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ARFORMOTEROL TARTRATE Form and strength SOLUTION;INHALATION - EQ 0.015MG BASE/2ML Sponsor MICRO LABS Submission history Latest submission status date: 2025-03-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview ARFORMOTEROL TARTRATE is listed in Drugs@FDA under application 218555 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ARFORMOTEROL TARTRATE Form and strength SOLUTION;INHALATION - EQ 0.015MG BASE/2ML Sponsor MICRO LABS Submission history Latest submission status date: 2025-03-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.